Business, energy, technology, markets and global industry news from Business News Today

biopharma R&D

PharmaDeviceNews biopharma R&D
Representative image showing AI-driven oncology research and cancer data analysis, reflecting Tempus AI’s Lens expansion into agentic AI tools for precision medicine and biopharma drug development.
Medical Devices & Diagnostics

Why Tempus AI’s Lens upgrade matters for precision oncology drug development

Tempus AI expands Lens with agentic AI for oncology drug development. Find out how it could reshape trials, evidence generation and biopharma R&D.

Read More
Medra raises $52 million to unify lab automation and AI for smarter drug R&D
Pharma & Biotech

Can Medra’s AI-powered lab scientists finally close the feedback loop in drug discovery?

Medra raises $52M to build AI-driven lab robots that run, learn, and optimize experiments. Learn how this startup is redefining drug discovery.

Read More